Glenmede Trust’s Asensus Surgical, Inc. ASXC Stock Holding History

Glenmede Trust’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,172	Closed	-$2K	–	2346
2020 Q3	$2K	Hold	7,172	–	–	﹤0.01%	2301
2020 Q2	$3K	Hold	7,172	–	–	﹤0.01%	2203
2020 Q1	$10K	Hold	7,172	–	–	﹤0.01%	2441
2019 Q4	$10K	Hold	7,172	–	–	﹤0.01%	2441
2019 Q3	$57	Hold	7,172	–	–	﹤0.01%	1603
2019 Q2	$126	Hold	7,172	–	–	﹤0.01%	1324
2019 Q1	$221	Hold	7,172	–	–	﹤0.01%	1147
2018 Q4	$210	Hold	7,172	–	–	﹤0.01%	1100
2018 Q3	$540K	Buy	+7,172	New	+$485K	﹤0.01%	876

Other funds holding ASXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Glenmede Trust's ASXC Position: Q4 2020 in Review

Glenmede Trust sold out of Asensus Surgical, Inc. (ASXC) in Q4 2020, closing a stake of 7,172 shares — an estimated $2K sold.

Glenmede Trust first reported a position in ASXC in Q3 2018 and held it in 9 quarters. The position peaked at $540K in Q3 2018. 65 funds tracked by Wall St. Rank hold ASXC as of Q4 2020.

Glenmede Trust reported no remaining Asensus Surgical, Inc. position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 7,172 Asensus Surgical, Inc. shares in Q4 2020, an estimated $2K.
Glenmede Trust first reported a position in Asensus Surgical, Inc. in Q3 2018 and held it in 9 quarters.
Glenmede Trust's Asensus Surgical, Inc. position peaked at $540K in Q3 2018.
65 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.